Aims and Scope
The Archives of Pharmacy and Pharmaceutical Sciences (APPS) publishes peer-reviewed research that advances drug discovery, development, evaluation, manufacturing, and the practice of pharmacy. This page summarizes APPS’s remit and the kinds of work welcomed by the journal.
Source: APPS — Aims and Scope.
Mission & Editorial Focus
According to the journal’s Aims and Scope page, APPS seeks literature that helps “redefine how drugs will be developed, evaluated and manufactured.” The journal prioritizes manuscripts that demonstrate methodological rigor, translational relevance, and clear implications for pharmaceutical science and pharmacy practice. Submissions should communicate results with transparency and sufficient detail to enable evaluation and reuse.
- Innovation across the pipeline: from early discovery to clinical translation and post-marketing safety.
- Reproducibility and clarity: well-controlled study designs, appropriate statistics, and complete reporting.
- Practical impact: insights that inform formulation choices, regulatory strategy, quality systems, or pharmacy practice.
APPS is positioned for an international readership of pharmaceutical scientists, pharmacists, clinicians, and policy stakeholders, and welcomes contributions from academic, clinical, and industry environments.
Core Scientific Domains
As reflected on the Aims & Scope and related journal pages, APPS considers submissions across the mainstream branches of pharmaceutical sciences and pharmacy practice. Representative (non-exhaustive) domains include:
Drug Discovery & Chemistry
- Medicinal and pharmaceutical chemistry
- Computational chemistry and in-silico screening
- Natural products, pharmacognosy, and chemoinformatics
Pharmaceutics & Delivery
- Preformulation, excipient science, and compatibility
- Dosage-form design; nanocarriers and targeted delivery
- Biopharmaceutics, bioavailability, and bioequivalence
Pharmacology & Therapeutics
- Pharmacokinetics/pharmacodynamics and modeling
- Clinical pharmacology and therapeutic drug monitoring
- Pharmacogenomics and precision therapeutics
Quality, Safety & Systems
- Pharmaceutical analysis and quality assurance
- Regulatory science, GMP, and validation
- Pharmacovigilance, risk management, and real-world data
Note on breadth: Submissions that bridge scientific silos—e.g., integrating formulation science with clinical outcomes, or linking computational discovery to experimental validation—are encouraged where appropriate to the journal’s mission.
Article Types Considered
APPS accepts a range of scholarly formats typical for pharmaceutical journals, as indicated by the journal’s public pages (Aims and Scope and adjacent “For Editors/Benefits” sections). Authors should choose the format that best matches the maturity of findings and the intended contribution:
Original Research
Full-length reports presenting new experimental, analytical, clinical, or practice-oriented findings with robust methodology and interpretation.
Short Communications
Concise studies reporting focused advances or timely methodological notes of high interest to the field.
Reviews & Mini-Reviews
Critical syntheses that survey and evaluate recent advances, clarify mechanisms, or map out priorities for future work.
Case Reports / Practice Reports
Well-documented cases or practice innovations with generalizable learning for pharmacists and pharmaceutical care.
Editorials / Perspectives
Brief commentaries on emerging issues, policy, or methodological rigor in pharmaceutical research and pharmacy practice.
Authors should consult the journal’s submission and author-guideline pages for detailed structural and formatting requirements before submission.
Translational Orientation
In alignment with the Aims and Scope statement, APPS encourages submissions that connect laboratory discoveries to clinical or manufacturing outcomes. Studies that clarify how formulation variables, process parameters, or patient factors influence efficacy and safety are particularly valued when supported by rigorous data and analysis plans.
- Demonstrate how results inform decisions in dosage-form selection, control strategy, or therapeutic optimization.
- Report assumptions, validation steps, and limitations to enable assessment and re-use of findings.
- Where relevant, contextualize results within regulatory expectations and quality-by-design paradigms.
Ethics, Access & Discoverability (Context)
The journal’s site indicates a double-blind review model and iThenticate screening, and describes its open-access paradigm and licensing on dedicated policy pages. Authors should anticipate routine checks for research ethics approvals (e.g., human/animal studies), informed consent where applicable, conflict-of-interest disclosures, and data availability statements proportionate to the work. See the journal’s Open Access Policy, Peer Review Policy, and Licensing Policy for details referenced on site.
Is My Manuscript a Fit for APPS?
Manuscripts are generally a good fit when they: (i) address a pharmaceutical question of broad relevance; (ii) use appropriate and transparent methods; (iii) communicate actionable implications for science, regulation, or practice; and (iv) align with at least one of the core domains listed above. Authors uncertain about scope are encouraged to contact the Editorial Office with a brief presubmission inquiry outlining title, abstract, and key contributions.